Open AccessNew approaches to managing patients with high total risk (review of year 2019 recommendations)
Author(s) -
Н. В. Орлова,
Т. В. Пинчук,
M. A. Laperishvili,
svetlana v . GOryaynOva
Publication year - 2020
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2020-2-24-28
Subject(s) - medicine , intensive care medicine , diabetes mellitus , disease , clinical trial , blood pressure , coronary heart disease , cause of death , cardiology , endocrinology
Cardiovascular disease is the leading cause of death worldwide. The current recommendations of the European Society of Cardiology (ESC) – 2019 are based on the results of large multicenter clinical trials that have proven the effectiveness of more stringent approaches to the management of patients with high cardiovascular risk. New regimens of drug therapy, the definition of new target values for blood pressure, blood lipid levels and the correction of hyperglycemia, the prevention of thromboembolic complications, are aimed at reducing the risk of cardiovascular events and mortality from cardiovascular diseases. The article discusses recommendations of the European Society of Cardiology – 2019 on the management of patients with chronic coronary disease, with lipid metabolism disorders, and diabetes mellitus.